VYNE Therapeutics to Participate in the 43rd Annual Cowen Health Care Conference
BRIDGEWATER, N.J., Feb. 22, 2023 (GLOBE NEWSWIRE) — VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”), a clinical-stage biopharmaceutical company developing proprietary, innovative, and differentiated therapies for the treatment of immuno-inflammatory conditions, today announced that David Domzalski, President and Chief Executive Officer, will participate in a fireside chat at the 43rd Annual Cowen Health Care Conference at the Boston Marriott Copley Place in Boston, Massachusetts, on March 7, 2023. Management will also be available for 1-on-1 meetings with investors. 43rd Annual Cowen Health Care Conference Presentation Details Fireside Chat: Tuesday, March 7th, 2023, at 2:10 PM ET Speaker: David…